How to buy Precision BioSciences stock (DTIL)

Precision BioSciences is a biotechnology business based in the US. Precision BioSciences shares (DTIL) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $4.72 – a decrease of 13.24% over the previous week. Precision BioSciences employs 108 staff and has a trailing 12-month revenue of around $75.1 million.

Our top picks for where to buy Precision BioSciences stock

Buy Precision BioSciences stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Precision BioSciences stock price (NASDAQ: DTIL)

Use our graph to track the performance of DTIL stocks over time.

Precision BioSciences shares at a glance

• Key figures

Information last updated 2024-12-18.

Latest market close	$4.72
52-week range	$4.13 - $19.43
50-day moving average more info button	$7.62
200-day moving average more info button	$10.01
Wall St. target price	$33.60
PE ratio more info button	10.325
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$0.40

Is it a good time to buy Precision BioSciences stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Precision BioSciences price performance over time

Historical closes compared with the close of $4.6 from 2024-12-19

1 week (2024-12-13)	-15.44%
1 month (2024-11-21)	-29.23%
3 months (2024-09-20)	-52.13%
6 months (2024-06-21)	-51.06%

1 year (2023-12-21)	1,199.44%
2 years (2022-12-21)	-85.53%
3 years (2021-12-21)	243.3
5 years (2019-12-20)	429.6

Is Precision BioSciences stock undervalued or overvalued?

Valuing Precision BioSciences stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Precision BioSciences's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Precision BioSciences's P/E ratio

Precision BioSciences's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 10x. In other words, Precision BioSciences shares trade at around 10x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

Precision BioSciences financials

Revenue TTM	$75.1 million
Gross profit TTM	$25.1 million
Return on assets TTM	-6.38%
Return on equity TTM	24.44%
Profit margin	11.48%
Book value	$8.67
Market Capitalization more info button	$31.7 million

TTM: trailing 12 months

Precision BioSciences share dividends

We're not expecting Precision BioSciences to pay a dividend over the next 12 months.

Have Precision BioSciences's shares ever split?

Precision BioSciences's shares were split on a 1:30 basis on 13 February 2024 . So if you had owned 30 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Precision BioSciences shares – just the quantity. However, indirectly, the new 2900% higher share price could have impacted the market appetite for Precision BioSciences shares which in turn could have impacted Precision BioSciences's share price.

Precision BioSciences share price volatility

Over the last 12 months, Precision BioSciences's shares have ranged in value from as little as $4.13 up to $19.43. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Precision BioSciences's is 1.693. This would suggest that Precision BioSciences's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Precision BioSciences overview

Precision BioSciences, Inc. , an advanced gene editing company, develops in vivo gene editing therapies for gene edits, including gene elimination, insertion, and excision in the United States. The company offers ARCUS, a genome editing platform to DNA genome insertion, deletion, and repair. It also provides PBGENE-HBV for the treatment of chronic hepatitis B virus (HBV) to eliminate covalently closed circular DNA with direct cuts and edits as well as to inactivate integrated HBV DNA with the goal of long-lasting reductions in hepatitis B surface antigen; PBGENE-PMM for the treatment of m. 3243 associated primary mitochondrial myopathy (PMM) which is expected to submit an IND and/or CTA. In addition, it develops PBGENE-NVS for sickle cell disease/beta thalassemia for insertion; PBGENE-DMD (excision) for duchenne muscular dystrophy; PBGENE-LL2 (insertion), a liver directed target; PBGENE-LL3, a central nervous system directed target; and iECURE-OTC (insertion) for ornithine transcarbamylase deficiency. The company has license and collaboration agreement with Caribou Biosciences, Inc.

Frequently asked questions

What percentage of Precision BioSciences is owned by insiders or institutions?
Currently 6.58% of Precision BioSciences shares are held by insiders and 44.696% by institutions. How many people work for Precision BioSciences?
Latest data suggests 108 work at Precision BioSciences. When does the fiscal year end for Precision BioSciences?
Precision BioSciences's fiscal year ends in December. Where is Precision BioSciences based?
Precision BioSciences's address is: 302 East Pettigrew Street, Durham, NC, United States, 27701 What is Precision BioSciences's ISIN number?
Precision BioSciences's international securities identification number is: US74019P1084 What is Precision BioSciences's CUSIP number?
Precision BioSciences's Committee on Uniform Securities Identification Procedures number is: 74019P108